Franklin Biotechnology Discv C(acc)USD

Performance History31/12/2017
Growth of 1,000 (ZAR)
Franklin Biotechnology Discv C(acc)USD
Fund101.547.939.8-28.05.3
+/-Cat6.53.9-3.81.0-4.0
+/-Idx-5.63.5-4.4-5.5-1.7
 
Key Stats
NAV
22/01/2018
 USD 39.93
Day Change 1.91%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0260873095
Fund Size (Mil)
31/12/2017
 USD 2613.38
Share Class Size (Mil)
31/12/2017
 USD 20.06
Max Initial Charge -
Ongoing Charge
27/01/2017
  2.41%
Investment Objective: Franklin Biotechnology Discv C(acc)USD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns22/01/2018
YTD4.17
3 Years Annualised2.46
5 Years Annualised23.84
10 Years Annualised20.60
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
09/06/2017
Christopher Lee
09/06/2017
Click here to see others
Inception Date
01/09/2006
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology PR USDMSCI World/Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Franklin Biotechnology Discv C(acc)USD31/12/2017
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stocks97.790.0097.79
Bonds0.000.000.00
Cash1.620.001.62
Other0.590.000.59
Top 5 Regions%
United States97.24
Eurozone0.92
United Kingdom0.70
Europe - ex Euro0.48
Canada0.38
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Celgene CorpHealthcareHealthcare7.91
Alexion Pharmaceuticals IncHealthcareHealthcare7.72
Biogen IncHealthcareHealthcare5.45
Vertex Pharmaceuticals IncHealthcareHealthcare4.42
Illumina IncHealthcareHealthcare4.40
Franklin Biotechnology Discv C(acc)USD